Hasil Pencarian - Christine L. Hann, MD

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations

    First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations oleh Tia Cheunkarndee, BA, Matthew Z. Guo, BA, Stefanie Houseknecht, PharmD, Josephine L. Feliciano, MD, Christine L. Hann, MD, PhD, Vincent K. Lam, MD, Benjamin P. Levy, MD, Joseph C. Murray, MD, PhD, Julie R. Brahmer, MD, Patrick M. Forde, MBBCh, Kristen A. Marrone, MD, Susan C. Scott, MD

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC

    Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC oleh Joshua E. Reuss, MD, Emily Brigham, MD, MHS, Kevin J. Psoter, PhD, Khinh Ranh Voong, MD, Bairavi Shankar, BS, David S. Ettinger, MD, Kristen A. Marrone, MD, Christine L. Hann, MD, Benjamin Levy, MD, Josephine L. Feliciano, MD, Julie R. Brahmer, MD, David Feller-Kopman, MD, Andrew D. Lerner, MD, Hans Lee, MD, Lonny Yarmus, DO, Russell K. Hales, MD, Franco D’Alessio, MD, Sonye K. Danoff, MD, PhD, Patrick M. Forde, MBBCH, Karthik Suresh, MD, Jarushka Naidoo, MBBCH, MHS

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: